Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
Holders of 5% or more of SIOX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sio Gene Therapies Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Sio Gene Therapies Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Sio Gene Therapies Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2023 | Suvretta Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Rubric Capital Management LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Consonance Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Suvretta Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 26, 2021 | Suvretta Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Sphera Funds Management Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Consonance Capital Management LP | 13GOld format | – | – | – | SEC |
| Feb 16, 2021 | Consonance Capital Management LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sio Gene Therapies Inc. shares.
No Form 144 notices for Sio Gene Therapies Inc. are on file.